US Stock MarketDetailed Quotes
BIO.B Bio-Rad Laboratories-B
- 334.850
- 0.0000.00%
Close Nov 8 16:00 ET
9.37BMarket Cap-11924P/E (TTM)
0.000High0.000Low11Volume368.340Open334.850Pre Close4.06KTurnover0.00%Turnover RatioLossP/E (Static)28.00MShares352.91052wk High1.25P/B6.68BFloat Cap279.91052wk Low--Dividend TTM19.96MShs Float818.600Historical High--Div YieldTTM0.00%Amplitude9.688Historical Low369.181Avg Price1Lot Size
Bio-Rad Laboratories-B Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.79%649.73M | -6.26%638.48M | -9.75%610.82M | -4.67%2.67B | -6.72%681.18M | -7.15%632.12M | -1.45%681.11M | -3.32%676.84M | -4.12%2.8B | -0.34%730.29M |
| Operating revenue | 2.79%649.73M | -6.26%638.48M | -9.75%610.82M | -4.67%2.67B | -6.72%681.18M | -7.15%632.12M | -1.45%681.11M | -3.32%676.84M | -4.12%2.8B | -0.34%730.29M |
| Cost of revenue | -0.88%293.83M | -11.07%283.36M | -9.41%284.85M | 0.76%1.24B | -5.51%314.82M | -3.83%296.44M | 7.62%318.63M | 5.72%314.43M | -3.86%1.23B | -0.34%333.19M |
| Gross profit | 6.02%355.9M | -2.03%355.12M | -10.06%325.97M | -8.96%1.43B | -7.74%366.36M | -9.90%335.68M | -8.24%362.48M | -9.99%362.42M | -4.32%1.57B | -0.34%397.1M |
| Operating expense | 19.08%291.44M | -7.05%253.62M | -6.40%281.26M | -0.28%1.09B | -5.20%271.05M | -11.94%244.73M | 0.27%272.87M | 17.28%300.5M | -4.00%1.09B | 1.92%285.93M |
| Selling and administrative expenses | -0.38%200.44M | -6.31%194.72M | -4.73%214.88M | 1.68%841.72M | -2.39%207.15M | -4.70%201.2M | 0.01%207.82M | 14.67%225.55M | -5.62%827.83M | -4.27%212.23M |
| Research and development costs | 109.02%91M | -9.44%58.9M | -11.44%66.38M | -3.68%247.43M | -3.48%63.9M | -34.84%43.54M | 1.08%65.04M | 25.89%74.95M | -1.44%256.89M | 12.48%66.2M |
| Other operating expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --7.5M | ---- |
| Operating profit | -29.12%64.47M | 13.26%101.5M | -27.79%44.71M | -28.90%337.8M | -14.26%95.32M | -3.91%90.95M | -27.08%89.62M | -57.71%61.91M | -5.04%475.12M | -5.70%111.17M |
| Net non-operating interest income expense | -32.15%3.33M | 4.31%4.34M | -42.78%21.72M | 158.78%51.46M | 619.45%4.44M | 233.82%4.9M | 179.64%4.16M | 1,037.82%37.96M | 14.62%19.89M | 476.22%617K |
| Non-operating interest income | -10.40%15.5M | 0.61%16.6M | -32.41%34M | 73.97%100.9M | 36.59%16.8M | 116.25%17.3M | 200.00%16.5M | --50.3M | 206.88%58M | 6,050.00%12.3M |
| Non-operating interest expense | -1.81%12.17M | -0.64%12.26M | -0.49%12.28M | 29.71%49.44M | 5.80%12.36M | 6.30%12.4M | 15.14%12.34M | 204.77%12.34M | 2,357.38%38.11M | 3,109.62%11.68M |
| Other net income (expense) | 1,826.58%793.85M | -81.42%-2.89B | 2,916.23%424.63M | 76.16%-1.24B | -66.46%328.56M | 113.81%41.21M | -19.16%-1.59B | 99.67%-15.08M | -205.43%-5.2B | 145.67%979.52M |
| Gain on sale of security | 1,987.22%793.25M | -81.43%-2.89B | 2,769.93%423.93M | 76.03%-1.24B | -66.63%328.66M | 112.95%38.01M | -19.07%-1.59B | 99.65%-15.88M | -205.26%-5.19B | 145.88%984.99M |
| Special income (charges) | --0 | ---- | ---- | 123.81%2.5M | --0 | 149.02%2.5M | ---- | ---- | -1,212.50%-10.5M | ---6.8M |
| -Write off | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 1,387.50%11.9M | ---- |
| -Gain on sale of business | --0 | ---- | ---- | 78.57%2.5M | --0 | --2.5M | ---- | ---- | --1.4M | --0 |
| Other non- operating income (expenses) | -14.29%600K | 100.00%1.6M | -12.50%700K | 0.00%2.3M | -107.51%-100K | 93.37%700K | 300.00%800K | -97.55%800K | 228.57%2.3M | -33.45%1.33M |
| Income before tax | 528.45%861.62M | -85.70%-2.79B | 478.90%491.08M | 81.93%-850.1M | -60.74%428.39M | 166.13%137.1M | -22.97%-1.5B | 101.94%84.83M | -186.33%-4.7B | 153.83%1.09B |
| Income tax | 575.79%208.45M | -83.57%-620.8M | 575.38%107.16M | 80.24%-212.78M | -70.14%78.68M | 169.30%30.85M | -14.60%-338.18M | 101.59%15.87M | -190.12%-1.08B | 157.06%263.55M |
| Net income | 514.71%653.17M | -86.32%-2.17B | 456.71%383.92M | 82.43%-637.32M | -57.75%349.71M | 165.27%106.26M | -25.63%-1.16B | 102.05%68.96M | -185.27%-3.63B | 152.88%827.73M |
| Net income continuous Operations | 514.71%653.17M | -86.32%-2.17B | 456.71%383.92M | 82.43%-637.32M | -57.75%349.71M | 165.27%106.26M | -25.63%-1.16B | 102.05%68.96M | -185.27%-3.63B | 152.88%827.73M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 514.71%653.17M | -86.32%-2.17B | 456.71%383.92M | 82.43%-637.32M | -57.75%349.71M | 165.27%106.26M | -25.63%-1.16B | 102.05%68.96M | -185.27%-3.63B | 152.88%827.73M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 514.71%653.17M | -86.32%-2.17B | 456.71%383.92M | 82.43%-637.32M | -57.75%349.71M | 165.27%106.26M | -25.63%-1.16B | 102.05%68.96M | -185.27%-3.63B | 152.88%827.73M |
| Basic earnings per share | 540.27%23.37 | -92.62%-76.26 | 477.68%13.46 | 82.08%-21.82 | -56.44%12.15 | 166.61%3.65 | -27.50%-39.59 | 102.07%2.33 | -185.40%-121.79 | 153.03%27.89 |
| Diluted earnings per share | 541.21%23.34 | -92.62%-76.26 | 479.74%13.45 | 82.08%-21.82 | -56.30%12.14 | 166.42%3.64 | -27.50%-39.59 | 102.06%2.32 | -186.48%-121.79 | 152.82%27.78 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data